{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:03:16Z","timestamp":1794643396598,"version":"4.9.1"},"reference-count":99,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,5,31]]},"abstract":"<jats:p>Cancer is a leading cause of death and disability in sub-Saharan Africa and will eclipse infectious diseases within the next several decades if current trends continue. Hematologic malignancies, including non-Hodgkin lymphoma, leukemia, Hodgkin lymphoma, and multiple myeloma, account for nearly 10% of the overall cancer burden in the region, and the incidence of non-Hodgkin lymphoma and Hodgkin lymphoma is rapidly increasing as a result of HIV. Despite an increasing burden, mechanisms for diagnosing, treating, and palliating malignant hematologic disorders are inadequate. In this review, we describe the scope of the problem, including the impact of endemic infections, such as HIV, Epstein-Barr virus, malaria, and Kaposi sarcoma\u2013associated herpesvirus. We additionally describe current limitations in hematopathology, chemotherapy, radiotherapy, hematopoietic stem cell transplantation, and supportive care and palliation. We review contemporary treatment and outcomes of hematologic malignancies in the region and outline a clinical service and research agenda, which builds on recent global health successes combating HIV and other infectious diseases. Achieving similar progress against hematologic cancers in sub-Saharan Africa will require the sustained collaboration and advocacy of the entire global cancer community.<\/jats:p>","DOI":"10.1182\/blood-2012-02-387092","type":"journal-article","created":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T00:12:53Z","timestamp":1332979973000},"page":"5078-5087","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":100,"title":["Meeting the challenge of hematologic malignancies in sub-Saharan Africa"],"prefix":"10.1182","volume":"119","author":[{"given":"Satish","family":"Gopal","sequence":"first","affiliation":[{"name":"Lineberger Comprehensive Cancer Center and"},{"name":"Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Wood","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Shea","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kikkeri N.","family":"Naresh","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Hammersmith Hospital Campus, Imperial College Healthcare National Health Service Trust & Imperial College London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter N.","family":"Kazembe","sequence":"additional","affiliation":[{"name":"Baylor International Pediatric AIDS Initiative, Lilongwe, Malawi;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Casper","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Disease, Public Health Science and Clinical Research Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA;"},{"name":"Departments of Medicine, Epidemiology, and Global Health, University of Washington, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Hesseling","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Child Health, Stellenbosch University, Stellenbosch, South Africa; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald T.","family":"Mitsuyasu","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine, Center for Clinical AIDS Research and Education, University of California, Los Angeles, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111813325621600_B1","unstructured":"Ferlay J Shin HR Bray F Forman D Mathers C Parkin DM GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Accessed January 2, 2012 http:\/\/globocan.iarc.fr"},{"key":"2019111813325621600_B2","unstructured":"Joint United Nations Program on HIV\/AIDS (UNAIDS) Global HIV\/AIDS response: progress report 2011. Accessed January 2, 2012 http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/unaidspublication\/2011\/20111130_UA_Report_en.pdf"},{"key":"2019111813325621600_B3","unstructured":"World Health Organization Global tuberculosis control 2011. Accessed January 2, 2012 http:\/\/www.who.int\/tb\/publications\/global_report\/2011\/gtbr11_full.pdf"},{"key":"2019111813325621600_B4","unstructured":"World Health Organization World Malaria Report 2010. Accessed January 2, 2012 http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241564106\/en\/index.html"},{"issue":"8","key":"2019111813325621600_B5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrc1948","article-title":"The evolution of the population-based cancer registry.","volume":"6","author":"Parkin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2019111813325621600_B6","unstructured":"International Agency for Research on Cancer Cancer incidence in five continents volumes I to IX. Accessed January 2, 2012 http:\/\/ci5.iarc.fr\/CI5i-ix\/ci5i-ix.htm"},{"key":"2019111813325621600_B7","unstructured":"World Health Organization WHO mortality database. Accessed January 2, 2012 http:\/\/www.who.int\/healthinfo\/morttables\/en\/"},{"issue":"5","key":"2019111813325621600_B8","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/ijc.24838","article-title":"Changing cancer incidence in Kampala, Uganda, 1991-2006.","volume":"126","author":"Parkin","year":"2010","journal-title":"Int J Cancer"},{"issue":"5","key":"2019111813325621600_B9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/1097-0215(20010601)92:5<687::AID-IJC1246>3.0.CO;2-Z","article-title":"Adult Burkitt's lymphoma in patients with and without human immunodeficiency virus infection in Kenya.","volume":"92","author":"Otieno","year":"2001","journal-title":"Int J Cancer"},{"issue":"5","key":"2019111813325621600_B10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/QAI.0b013e31820bb06a","article-title":"Changing pattern of lymphoma subgroups at a tertiary academic complex in a high prevalence HIV setting: a South African perspective.","volume":"56","author":"Wiggill","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"2019111813325621600_B11","first-page":"69","article-title":"AIDS and non-AIDS-related malignant lymphoma in Tanzania.","volume":"6","author":"Kaaya","year":"2006","journal-title":"Afr Health Sci"},{"key":"2019111813325621600_B12","doi-asserted-by":"crossref","first-page":"578163","DOI":"10.1155\/2011\/578163","article-title":"Human immunodeficiency virus infection and Hodgkin's lymphoma in South Africa: an emerging problem.","volume":"2011","author":"Patel","year":"2011","journal-title":"Adv Hematol"},{"issue":"12","key":"2019111813325621600_B13","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002.","volume":"118","author":"Parkin","year":"2006","journal-title":"Int J Cancer"},{"issue":"10","key":"2019111813325621600_B14","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-148-10-200805200-00005","article-title":"Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.","volume":"148","author":"Patel","year":"2008","journal-title":"Ann Intern Med"},{"issue":"12","key":"2019111813325621600_B15","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980-2002.","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"issue":"9581","key":"2019111813325621600_B16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"2019111813325621600_B17","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/ijc.21443","article-title":"Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study.","volume":"118","author":"Mbulaiteye","year":"2006","journal-title":"Int J Cancer"},{"issue":"1","key":"2019111813325621600_B18","doi-asserted-by":"crossref","first-page":"e8621","DOI":"10.1371\/journal.pone.0008621","article-title":"The challenge of AIDS-related malignancies in sub-Saharan Africa.","volume":"5","author":"Sasco","year":"2010","journal-title":"PLoS One"},{"issue":"23","key":"2019111813325621600_B19","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1182\/blood-2010-08-301531","article-title":"HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ T-cell lymphocytes.","volume":"117","author":"Bohlius","year":"2011","journal-title":"Blood"},{"issue":"8","key":"2019111813325621600_B20","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1086\/656416","article-title":"Cancer as a cause of death among people with AIDS in the United States.","volume":"51","author":"Simard","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2019111813325621600_B21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/596766","article-title":"Changes in cancer mortality among HIV-infected patients: the Mortalit\u00e9 2005 Survey.","volume":"48","author":"Bonnet","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2019111813325621600_B22","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/652283","article-title":"Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies.","volume":"50","author":"Antiretroviral Therapy Cohort Collaboration","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2019111813325621600_B23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/01.qai.0000371677.48743.8d","article-title":"Immunologic and virologic predictors of AIDS-related non-Hodgkin lymphoma in the highly active antiretroviral therapy era.","volume":"54","author":"Engels","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"2019111813325621600_B24","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S1470-2045(09)70282-7","article-title":"Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.","volume":"10","author":"Guiguet","year":"2009","journal-title":"Lancet Oncol"},{"issue":"12","key":"2019111813325621600_B25","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1158\/1055-9965.EPI-11-0777","article-title":"HIV infection, immunodeficiency, viral replication, and the risk of cancer.","volume":"20","author":"Silverberg","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"2019111813325621600_B26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1182\/blood-2011-02-339275","article-title":"HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy.","volume":"118","author":"Lanoy","year":"2011","journal-title":"Blood"},{"issue":"12","key":"2019111813325621600_B27","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1182\/blood-2006-05-024109","article-title":"Hodgkin lymphoma and immunodeficiency in persons with HIV\/AIDS.","volume":"108","author":"Biggar","year":"2006","journal-title":"Blood"},{"issue":"6","key":"2019111813325621600_B28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/cid\/ciq243","article-title":"The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection.","volume":"52","author":"Gardner","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2019111813325621600_B29","unstructured":"World Health Organization Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach: 2010 revision. Accessed January 2, 2012 http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599764_eng.pdf"},{"key":"2019111813325621600_B30","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents Guidelines for the use of antiretroviral agents in HIV-1 infected adolescents and adults. Accessed January 2, 2012 http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf"},{"issue":"3","key":"2019111813325621600_B31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.2010.1004","article-title":"Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.","volume":"304","author":"Thompson","year":"2010","journal-title":"JAMA"},{"key":"2019111813325621600_B32","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/1471-2407-10-344","article-title":"Tanzanian malignant lymphomas: WHO classification, presentation, ploidy, proliferation and HIV\/EBV association.","volume":"10","author":"Mwakigonja","year":"2010","journal-title":"BMC Cancer"},{"issue":"4","key":"2019111813325621600_B33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/QAI.0b013e31820c011a","article-title":"Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited setting: a retrospective study on the impact of HIV infection and its treatment.","volume":"56","author":"Bateganya","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"2019111813325621600_B34","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1365-2141.2011.08772.x","article-title":"Lymphomas in sub-Saharan Africa: what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?","volume":"154","author":"Naresh","year":"2011","journal-title":"Br J Haematol"},{"issue":"15","key":"2019111813325621600_B35","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1182\/blood-2009-08-231613","article-title":"Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.","volume":"115","author":"Sparano","year":"2010","journal-title":"Blood"},{"issue":"15","key":"2019111813325621600_B36","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1097\/QAD.0b013e32832e531c","article-title":"Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy.","volume":"23","author":"Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study group","year":"2009","journal-title":"AIDS"},{"issue":"4","key":"2019111813325621600_B37","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/QAI.0b013e31815e722b","article-title":"Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy.","volume":"47","author":"Berenguer","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"2019111813325621600_B38","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/QAD.0b013e32833a0961","article-title":"Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy.","volume":"24","author":"Chao","year":"2010","journal-title":"AIDS"},{"issue":"12","key":"2019111813325621600_B39","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.trstmh.2011.08.008","article-title":"Clinical characteristics, treatment and outcome of childhood Burkitt's lymphoma at the Uganda Cancer Institute.","volume":"105","author":"Orem","year":"2011","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"21","key":"2019111813325621600_B40","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1200\/JCO.2008.18.7641","article-title":"Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.","volume":"27","author":"Mwanda","year":"2009","journal-title":"J Clin Oncol"},{"issue":"13","key":"2019111813325621600_B41","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein-Barr virus and the origins of associated lymphomas.","volume":"350","author":"Thorley-Lawson","year":"2004","journal-title":"N Engl J Med"},{"issue":"7","key":"2019111813325621600_B42","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection.","volume":"343","author":"Cohen","year":"2000","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111813325621600_B43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ijc.2910220304","article-title":"Primary Epstein-Barr virus infections in African infants: I. Decline of maternal antibodies and time of infection.","volume":"22","author":"Biggar","year":"1978","journal-title":"Int J Cancer"},{"issue":"2","key":"2019111813325621600_B44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.virusres.2009.07.005","article-title":"The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.","volume":"143","author":"Chang","year":"2009","journal-title":"Virus Res"},{"issue":"1","key":"2019111813325621600_B45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.2910060102","article-title":"Burkitt's lymphoma and malaria.","volume":"6","author":"Kafuko","year":"1970","journal-title":"Int J Cancer"},{"issue":"4","key":"2019111813325621600_B46","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/oxfordjournals.aje.a115189","article-title":"Effect of a malaria suppression program on the incidence of African Burkitt's lymphoma.","volume":"129","author":"Geser","year":"1989","journal-title":"Am J Epidemiol"},{"issue":"6","key":"2019111813325621600_B47","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/ijc.23254","article-title":"Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda.","volume":"122","author":"Carpenter","year":"2008","journal-title":"Int J Cancer"},{"issue":"6","key":"2019111813325621600_B48","doi-asserted-by":"crossref","first-page":"e2505","DOI":"10.1371\/journal.pone.0002505","article-title":"Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study.","volume":"3","author":"Mutalima","year":"2008","journal-title":"PLoS One"},{"issue":"8","key":"2019111813325621600_B49","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/ijc.26203","article-title":"Antibodies reactive to Plasmodium falciparum serine repeat antigen in children with Burkitt lymphoma from Ghana.","volume":"130","author":"Guech-Ongey","year":"2012","journal-title":"Int J Cancer"},{"issue":"8746","key":"2019111813325621600_B50","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0140-6736(91)90203-2","article-title":"Circulating Epstein-Barr virus-carrying B cells in acute malaria.","volume":"337","author":"Lam","year":"1991","journal-title":"Lancet"},{"issue":"6","key":"2019111813325621600_B51","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1371\/journal.ppat.0030080","article-title":"A molecular link between malaria and Epstein-Barr virus reactivation.","volume":"3","author":"Ch\u00eane","year":"2007","journal-title":"PLoS Pathog"},{"issue":"11","key":"2019111813325621600_B52","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/ijc.23800","article-title":"Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited.","volume":"123","author":"Ogwang","year":"2008","journal-title":"Int J Cancer"},{"issue":"8","key":"2019111813325621600_B53","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nm0896-925","article-title":"KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.","volume":"2","author":"Gao","year":"1996","journal-title":"Nat Med"},{"issue":"2","key":"2019111813325621600_B54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/518791","article-title":"Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission.","volume":"196","author":"Engels","year":"2007","journal-title":"J Infect Dis"},{"issue":"3","key":"2019111813325621600_B55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/sti.2005.016568","article-title":"HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study.","volume":"82","author":"Casper","year":"2006","journal-title":"Sex Transm Infect"},{"issue":"6","key":"2019111813325621600_B56","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/(SICI)1097-0215(19980911)77:6<817::AID-IJC2>3.0.CO;2-X","article-title":"Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents.","volume":"77","author":"Mayama","year":"1998","journal-title":"Int J Cancer"},{"issue":"2","key":"2019111813325621600_B57","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.humpath.2006.08.009","article-title":"Kaposi sarcoma-associated herpesvirus in non-Hodgkin lymphoma and reactive lymphadenopathy in Uganda.","volume":"38","author":"Engels","year":"2007","journal-title":"Hum Pathol"},{"key":"2019111813325621600_B58","unstructured":"World Bank Agriculture and rural development. Accessed January 2, 2012 http:\/\/data.worldbank.org\/topic\/agriculture-and-rural-development"},{"key":"2019111813325621600_B59","unstructured":"Pasquini MC Wang Z Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides, 2011. Accessed January 2, 2012 http:\/\/www.cibmtr.org"},{"key":"2019111813325621600_B60","unstructured":"International Atomic Energy Agency Directory of radiotherapy centers, 2011. Accessed January 2, 2012 http:\/\/www-naweb.iaea.org\/nahu\/dirac\/"},{"issue":"11","key":"2019111813325621600_B61","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.5858\/2007-131-1636-PSIDCA","article-title":"Pathology services in developing countries: a challenge.","volume":"131","author":"Benediktsson","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"2019111813325621600_B62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/PLMI.S9779","article-title":"Role of pathology in sub-Saharan Africa: an example from Sudan.","volume":"2","author":"Awadelkarim","year":"2010","journal-title":"Pathol Lab Med Int"},{"key":"2019111813325621600_B63","volume-title":"Physician Characteristics and Distribution in the US","author":"American Medical Association","year":"2011","edition":"2011 Ed"},{"key":"2019111813325621600_B64","unstructured":"World Health Organization WHO model lists of essential medicines. Accessed January 2, 2012 http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/index.html"},{"key":"2019111813325621600_B65","first-page":"S106","article-title":"The GLIVEC international patient assistance programme: the Nairobi experience.","volume":"86","author":"Kiarie","year":"2009","journal-title":"East Afr Med J"},{"key":"2019111813325621600_B66","unstructured":"United Nations MDG Gap Task Force Report 2011. Accessed January 2, 2012 http:\/\/www.who.int\/medicines\/mdg\/en\/index.html"},{"issue":"9747","key":"2019111813325621600_B67","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(10)61152-X","article-title":"Expansion of cancer care and control in countries of low and middle income: a call to action.","volume":"376","author":"Farmer","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"2019111813325621600_B68","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S1470-2045(06)70759-8","article-title":"Role of radiotherapy in cancer control in low-income and middle-income countries.","volume":"7","author":"Barton","year":"2006","journal-title":"Lancet Oncol"},{"key":"2019111813325621600_B69","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1748-717X-6-11","article-title":"International Conference on Advances in Radiation Oncology (ICARO): outcomes of an IAEA meeting.","volume":"6","author":"Salminen","year":"2011","journal-title":"Radiat Oncol"},{"issue":"16","key":"2019111813325621600_B70","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.2010.491","article-title":"Hematopoietic stem cell transplantation: a global perspective.","volume":"303","author":"Gratwohl","year":"2010","journal-title":"JAMA"},{"issue":"23","key":"2019111813325621600_B71","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"issue":"8852","key":"2019111813325621600_B72","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0140-6736(93)92411-L","article-title":"Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial.","volume":"341","author":"Linch","year":"1993","journal-title":"Lancet"},{"issue":"7","key":"2019111813325621600_B73","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/bmt.2009.330","article-title":"Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes.","volume":"45","author":"McDiarmid","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2019111813325621600_B74","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3727\/096368910X528076","article-title":"Stem cell transplantation for lymphoma patients with HIV infection.","volume":"20","author":"Michieli","year":"2011","journal-title":"Cell Transplant"},{"issue":"1","key":"2019111813325621600_B75","first-page":"125","article-title":"Aerodigestive tract, lung and haematological cancers are risk factors for tuberculosis: an 8-year population-based study.","volume":"15","author":"Wu","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"2019111813325621600_B76","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1179\/146532808X302125","article-title":"Tuberculosis in oncology patients.","volume":"28","author":"Stefan","year":"2008","journal-title":"Ann Trop Paediatr"},{"issue":"9761","key":"2019111813325621600_B77","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(10)61458-4","article-title":"Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis.","volume":"377","author":"Allegranzi","year":"2011","journal-title":"Lancet"},{"issue":"9808","key":"2019111813325621600_B78","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0140-6736(11)61622-X","article-title":"Risk and causes of paediatric hospital-acquired bacteraemia in Kilifi District Hospital, Kenya: a prospective cohort study.","volume":"378","author":"Aiken","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"2019111813325621600_B79","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America.","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2019111813325621600_B80","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/08880010600631979","article-title":"Improved outcome in South African children of mixed ethnicity treated for ALL.","volume":"23","author":"Dippenaar","year":"2006","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"2019111813325621600_B81","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/pbc.22032","article-title":"Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi.","volume":"53","author":"Isra\u00ebls","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2019111813325621600_B82","doi-asserted-by":"crossref","first-page":"e10924","DOI":"10.1371\/journal.pone.0010924","article-title":"An epidemiologic review of enteropathogens in Gaborone, Botswana: shifting patterns of resistance in an HIV endemic region.","volume":"5","author":"Rowe","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"2019111813325621600_B83","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1086\/505866","article-title":"Surveillance for bacterial diarrhea and antimicrobial resistance in rural western Kenya, 1997-2003.","volume":"43","author":"Brooks","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2019111813325621600_B84","unstructured":"Tapko J Mainuka P Diarra-Nama AJ Status of blood safety in the WHO African region: report of the 2006 survey. Accessed January 2, 2012 http:\/\/www.afro.who.int\/en\/clusters-a-programmes\/hss\/blood-safety-laboratories-a-health-technology.html"},{"issue":"2","key":"2019111813325621600_B85","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.tmrv.2011.07.006","article-title":"Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges.","volume":"26","author":"Bloch","year":"2012","journal-title":"Transfus Med Rev"},{"issue":"9475","key":"2019111813325621600_B86","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/S0140-6736(05)66666-4","article-title":"Palliative care in sub-Saharan Africa.","volume":"365","author":"Harding","year":"2005","journal-title":"Lancet"},{"key":"2019111813325621600_B87","unstructured":"World Health Organization A community health approach to palliative care for HIV and cancer patients in Africa. Accessed January 2, 2012 http:\/\/www.who.int\/cancer\/palliative\/africanproject\/en\/index.html"},{"issue":"6","key":"2019111813325621600_B88","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/pbc.21452","article-title":"Treatment of B-cell lymphoma with LMB modified protocols in Africa: report of the French-African Pediatric Oncology Group (GFAOP).","volume":"50","author":"Harif","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2019111813325621600_B89","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pbc.22746","article-title":"Cyclophosphamide monotherapy in children with Burkitt lymphoma: a study from the French-African Pediatric Oncology Group (GFAOP).","volume":"56","author":"Traor\u00e9","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2019111813325621600_B90","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/08880018.2011.644881","article-title":"The Cameroon 2008 Burkitt lymphoma protocol: improved event-free survival with treatment adapted to disease stage and the response to induction therapy.","volume":"29","author":"Hesseling","year":"2012","journal-title":"Pediatr Hematol Oncol"},{"issue":"5","key":"2019111813325621600_B91","first-page":"497","article-title":"Treatment of childhood cancer in Africa: action of the Franco-African childhood cancer group.","volume":"67","author":"Lemerle","year":"2007","journal-title":"Med Trop (Mars)"},{"issue":"5","key":"2019111813325621600_B92","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/pbc.21889","article-title":"Treatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low-income countries: a proposal.","volume":"52","author":"Hunger","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2019111813325621600_B93","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1365-2141.2011.08771.x","article-title":"Diagnosis of Burkitt lymphoma using an algorithmic approach: applicable in both resource-poor and resource-rich countries.","volume":"154","author":"Naresh","year":"2011","journal-title":"Br J Haematol"},{"issue":"8","key":"2019111813325621600_B94","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/cid\/cis015","article-title":"Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving first-line antiretroviral therapy.","volume":"54","author":"Rottinghaus","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"9776","key":"2019111813325621600_B95","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","article-title":"Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.","volume":"377","author":"Boehme","year":"2011","journal-title":"Lancet"},{"key":"2019111813325621600_B96","unstructured":"Clinton Health Access Initiative Antiretroviral (ARV) ceiling price list. Accessed March 13, 2012 http:\/\/www.clintonfoundation.org\/files\/chai_arv_ceilingPriceList_201105_english.pdf"},{"key":"2019111813325621600_B97","unstructured":"Beaulieu N Bloom D Bloom R Stein R Breakaway: the global burden of cancer\u2014challenges and opportunities. A report from the Economist Intelligence Unit. Accessed January 10, 2012 http:\/\/livestrongblog.org\/GlobalEconomicImpact.pdf"},{"key":"2019111813325621600_B98","unstructured":"Joint United Nations Program on HIV\/AIDS (UNAIDS) UNAIDS report on the global AIDS epidemic 2010. Accessed January 12, 2012 http:\/\/www.unaids.org\/globalreport\/Global_report.htm"},{"issue":"9734","key":"2019111813325621600_B99","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0140-6736(10)60894-X","article-title":"Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial.","volume":"376","author":"Sanne","year":"2010","journal-title":"Lancet"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/22\/5078\/1492481\/zh802212005078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/22\/5078\/1492481\/zh802212005078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T13:44:00Z","timestamp":1641649440000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/22\/5078\/105482\/Meeting-the-challenge-of-hematologic-malignancies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,31]]},"references-count":99,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2012,5,31]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-02-387092","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,31]]}}}